About Celartia
Celartia is a Healthcare company based in Columbus (United States) founded in 2002. It offers tools for growing, transporting, and investigating live cells in controlled environments. It operates on a B2B and D2C model. Celartia offers products and services including Petaka G3, Physioxia Chambers, and Incubator. Its focus areas include Life Sciences, Biotechnology, Cell Culture and Hypoxia Control. Its competitors include PBS Biotech and Hyalose; 1 of its 2 listed competitors has raised funding.
Company details
Celartia specializes in innovative devices like Petaka G3 for hypoxia control in cell culture, transforming traditional methods into standardized scientific processes. The company focuses on tools for biological research, molecule production, and tissue repair, ensuring consistent results for laboratories and medical applications. Based in Columbus, Ohio, USA, Celartia supports researchers by enabling efficient cell growth under real physiological conditions.
- Headquarters Columbus, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website celartia.com
- Social X Facebook
Products & Services of Celartia
Celartia offers a comprehensive portfolio of products and services, including Petaka G3, Physioxia Chambers, and Incubator.
Disposable chamber for physioxia and hypoxia control in cell growth
Tools for maintaining physiological conditions in cell research
Device for optimal cell culture environments and shipping
Competitors of Celartia
Celartia has 2 listed competitors in our database, 1 of them funded. They include PBS Biotech and Hyalose.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pbsbiotech.com | 2006 | Camarillo, United States | $70.21M | Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies | ||
| hyalose.com | 2000 | Oklahoma, United States | Recombinant hyaluronic acid is manufactured in varying molecular sizes. |
Detailed competitors of Celartia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Celartia
Websites that share an audience with Celartia (celartia.com).
Websites whose visitors overlap most with Celartia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| synthecon.com | 100% | 1.7K | #9,630,679 | View details | |
| glycosan.com | 96% | View details | |||
| cyagen.com | 80% | 36.4K | #932,590 | View details | |
| chemometec.com | 79% | 31.8K | #992,798 | View details | |
| irvinesci.com | 73% | 6.6K | #3,329,806 | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as Celartia (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Celartia
Complete news archive for Celartia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celartia
Celartia was founded in 2002.
Celartia is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Celartia specializes in innovative devices like Petaka G3 for hypoxia control in cell culture, transforming traditional methods into standardized scientific processes. The company focuses on tools for biological research, molecule production, and tissue repair, ensuring consistent results for laboratories and medical applications. Based in Columbus, Ohio, USA, Celartia supports researchers by enabling efficient cell growth under real physiological conditions.
Celartia's top competitors include PBS Biotech and Hyalose.
Celartia offers Petaka G3, Physioxia Chambers, and Incubator.